PDGFR-β in stromal cells has been shown to enhance EMT, cancer cell stemness, and angiogenesis, thereby promoting metastasis and resulting in poor survival in patients with prostate cancer 30 and in patients with BM of breast cancer 31. This evidence concerns the gene PDGFRB and breast cancer.